000 | 00918nmm a2200313Ia 4500 | ||
---|---|---|---|
008 | 140908s9999 xx 000 0 und d | ||
020 | _a9783540790860, 978-3-540-79086-0 | ||
040 | _aNISER LIBRARY | ||
041 | _aEnglish | ||
082 |
_a615, _b23 |
||
245 | _aAntiviral Strategies | ||
260 |
_aBerlin, Heidelberg _bSpringer Berlin Heidelberg _c2009. |
||
500 | _aBiomedical and Life Sciences (Springer-11642) | ||
650 | _aBiomedicine | ||
650 | _aDrug interactions | ||
650 | _aDrug Resistance | ||
650 | _aGene therapy | ||
650 | _aGene Therapy | ||
650 | _aMedical virology | ||
650 | _aMedicine | ||
650 | _aPharmaceutical Sciences/Technology | ||
650 | _aPharmaceutical technology | ||
650 | _aPharmacology/Toxicology | ||
650 | _aToxicology | ||
650 | _aVirology | ||
700 | _aKrausslich, Hans-Georg | ||
856 | _uhttp://dx.doi.org/10.1007/978-3-540-79086-0 | ||
942 | _cEB | ||
999 |
_c18328 _d18328 |